wound care
-
Biologics
Biogennix Launches Agilon Surgical Matrix
Osteobiologics Leader Enters Wound Care Space with Cutting Edge Solution IRVINE, Calif., July 24, 2024 – OrthoSpineNews – Biogennix, an…
Read More » -
Biologics
Kerecis Expands Silicone Fish-Skin Combination Product Range with Shield Spiral, Offering Advanced Customizable Wound Care Solutions
Product offers added benefit of flexible graft tailoring to fit various wound sizes ARLINGTON, Va., July 5, 2024 –(BUSINESS WIRE)–…
Read More » -
Biologics
MTF Biologics and Centurion Therapeutics Partner to Expand Access to Advance Wound Care Technologies
Organizations build on existing relationship, forging new agreement aimed at growing distribution of wound care innovations in acute care and…
Read More » -
Financial
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
Exclusive agreement provides MIMEDX with rights to commercialize 510(k) cleared, bovine-derived collagen matrix particulate that is indicated for the management…
Read More » -
Biologics
LifeNet Health acquires best-in-class wound care portfolio
The acquisition of Bioventus Inc.’s wound care division includes all its dedicated professionals VIRGINIA BEACH, Va., May 10, 2023 /PRNewswire/ — LifeNet…
Read More » -
Biologics
MTF Biologics Unveils New Tissue Form: AlloPatch® Pliable Meshed – Acellular Human Reticular Dermal Allograft
Innovative allograft offers new treatment option for diabetic foot ulcers and venous leg ulcers EDISON, N.J., April 17, 2023–(BUSINESS WIRE) —MTF…
Read More » -
Biologics
SmartTRAK Advances Medtech Market Insights Platform; Announces New Modules for Wound Care and Orthopedic/Spine Injectables
SmartTRAK, the leading global Medtech business and market insights platform in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy…
Read More » -
Biologics
Collagen Matrix, Inc. Announces 510(k) Clearance for Fibrillar Collagen Wound Dressing, Expanding Offerings for Advanced Wound Market
OAKLAND, N.J., June 28, 2022 /PRNewswire/ — Collagen Matrix, Inc., a leader in regenerative medicine, global manufacturer of collagen and other biomaterial-based medical…
Read More » -
Biologics
Royal Biologics Wound Care Portfolio Receives High-Tier Reimbursement
Royal Biologics’ Cryo-Cord™, Amnio-Maxx™, Amnio-Maxx™ Lite and Derm-Maxx™ Receive High-Tier Reimbursement in the Hospital Outpatient Departments and Reimbursement in the…
Read More » -
Biologics
Royal Biologics Completes 100th Cryo Cord™ Case, Successfully Enrolls First Patient Into Diabetic Foot Ulcer Study
HACKENSACK, N.J., September 18, 2020 (Newswire.com) – Royal Biologics, an ortho-biologics company specializing in the research and advancement of novel ortho-biologics…
Read More » -
Biologics
SANUWAVE Health Enters Into Exclusive Letter of Intent to Acquire Celularity’s UltraMIST® and Exclusive Partnership Rights for Wound Care Biologic Products
SUWANEE, GA, June 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has entered into…
Read More » -
Biologics
SANUWAVE Health to Deliver dermaPACE® to Patients in the Home Setting
SUWANEE, GA, May 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) is pleased to announce they will be…
Read More » -
Biologics
Organogenesis Announces Virtual Education Events for April
CANTON, Mass., April 13, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development,…
Read More » -
Biologics
Royal Biologics Announces The Launch of CRYO-CORD™ The First NON-DMSO Viable Umbilical Cord Graft
–Debuts at the NY20 Foundation for Podiatric Medicine Meeting– HACKENSACK, N.J., January 21, 2020 —Royal Biologics, an ortho-biologics company specializing…
Read More » -
Biologics
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products
Pompano Beach, FL, Oct. 01, 2018 (GLOBE NEWSWIRE) — BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned…
Read More »